Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-15

Clinical Trial Update: Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Loteprednol etabonate with Tobramycin versus Tobramycin with Dexamethasone for blepharokeratoconjunctivitis has completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Lotemax (Loteprednol etabonate) (Loteprednol etabonate)
  • TOBRAMYCIN (Tobramycin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Conjunctivitis, Keratitis | Phase 3 | Status: COMPLETED | Results posted: 2011-09-15